Top 5 in lung from ASCO 2021
Highlights from ASCO 2021 in lung cancer! Learn more about the major clinical trials reported at this year’s meeting.
Key updates from EAU 2021
VJOncology presents highlights from this year’sEuropean Association of Urology (EAU) Virtual Meeting 2021!
Top 5 in GI from ASCO 2021
VJOncology brings you highlights in GI cancer from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!
Top picks from ASCO 2021
VJOncology presents highlights from this year’s virtual American Society of Clinical Oncology (ASCO) annual meeting!
Dostarlimab subject to accelerated FDA approval for the treatment of advanced dMMR endometrial cancer
The Food and Drug Administration (FDA) granted accelerated approval to dostarlimab on April 2021 for patients with recurrent or advanced…
Key updates from ESMO Breast 2021
VJOncology presents highlights from this year’s virtual European Society for Medical Oncology (ESMO) Breast Cancer Congress!
St Gallen 2021 Highlights
VJOncology are excited to present some key abstracts and trial updates announced at this year’s virtual St. Gallen Breast Cancer…
Accelerating the pace from bench to beside: the NIHR Oncology Translational Research Collaboration
In a nationwide effort to prioritize and accelerate translational research, a brand-new oncology research collaboration has been established by The…
WCLC 2021 Highlights
VJOncology are pleased to bring you our top picks from the recent virtual WCLC meeting
Head and neck cancer updates presented at ESMO 2020
EPIC-OPC study: misclassification of OPC patients The presence of human papillomavirus p16 alone is not sufficient to classify oropharyngeal cancer…
Sig3 mutation and immune score determine responses to combination PARP and PD-1 inhibition in ovarian cancer
Immune checkpoint inhibitors have shown promising therapeutic outcomes in many types of cancer, but ovarian cancer has been an exception….